Brian C. Thomas

This profile gathers the share dealings of Brian C. Thomas in Metagenomi Therapeutics, Inc. We count 5 filings; the first trade dates from 1 April 2024 and the latest from 5 December 2025.

On the market, this insider has only sold: 3 sales, €27k in total. Besides market trades, the filings include 2 share grants. So far in 2025, the count stands at no purchases and 3 sales.

On 8 December 2025 came the latest disclosure, an open-market sale for €5,829 in Metagenomi Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.